- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Billed for 8 Lanzol Junior Tablets, Supplied 7: Karnataka HC Quashes Rs 1.12 Case Against MedPlus

Justice S. Vishwajith Shetty passed the order on November 13, 2026, allowing Criminal Petition Nos. 355 of 2023 and 447 of 2023. The petitions sought to quash proceedings in C.C. No. 7712/2019, pending before the III Additional Metropolitan Magistrate, Bengaluru, under Clause 26 of the Drugs (Price Control) Order, 2013, and Section 7(1)(a)(ii) of the Essential Commodities Act, 1955. The order bears neutral citation 2026:KHC:63320.
The dispute originated in a purchase allegedly made on August 23, 2016, when Lanzol Junior 15 mg tablets were supplied to Shrinath Joshi, a senior reporter with ETV Kannada News, Bengaluru. According to the allegations reproduced in the order, the bill recorded a collection of Rs 40.32 for eight tablets, but only seven tablets were supplied. The complaint also alleged that the accused had collected Rs 1.12 in excess.
Joshi lodged a complaint on August 26, 2016. Subsequently, the Assistant Drugs Controller-I, Bengaluru Circle-4, instituted a private complaint against the accused for the alleged statutory offences. The High Court’s order records the billing amount, tablet shortage and alleged excess collection but does not explain the calculation underlying the Rs 1.12 figure.
Five accused challenged the resulting criminal proceedings through two petitions filed under Section 482 of the Code of Criminal Procedure. Criminal Petition No. 355/2023 was filed by P. Srinivas, described as a director of MedPlus, a unit of Rite Med Pharma Retail Pvt. Ltd., and M. Surendranath, described as its director in charge. They were accused Nos. 3 and 4 in the criminal case.
The connected Criminal Petition No. 447/2023 was filed by MedPlus, Padmanabhanagar, Bengaluru, its authorised signatory Sudhakar Reddy, and Rangaswamy K, described as the person in charge. They were accused Nos. 1, 2 and 5, respectively.
The petitioners, represented by advocate Akki Manjunath Gowda K, sought quashing of the entire proceedings against them. The State of Karnataka, acting through the Assistant Drugs Controller-I, Bengaluru Circle-4, was represented by High Court Government Pleader Rahul Rai K.
Although the court recorded that it heard counsel for both sides, the brief order does not separately reproduce their detailed oral submissions. The petitioners’ recorded request was to terminate the prosecution, while the prosecution case rested on the alleged shortage in the tablets supplied and the claimed excess collection. The order does not record a separate defence explanation for the transaction or a detailed State response supporting the application of Clause 26.
The central question examined by the court was whether those allegations attracted the specific price-control provision invoked in the complaint. Clause 26 regulates the price at which formulations may be sold to consumers.
The court reproduced the provision as follows:
“26. Control of sale prices of formulations.- No person shall sell any formulation to any consumer at a price exceeding the price specified in the current price list or price indicated on the label of the container or pack thereof, whichever is less.”
Interpreting the clause, Justice Shetty explained that it would apply where a formulation was sold at a price exceeding the price specified in the current price list or indicated on its container or pack, whichever was lower. The court therefore examined whether the prosecution had alleged that particular form of overpricing.
It found that the complaint instead concerned the supply of seven tablets against a bill for eight, together with the alleged excess collection of Rs 1.12. The court noted that the prosecution had not alleged that the accused charged more than the applicable price contemplated by the provision.
In paragraph 6, the court observed:
“In the case on hand, the allegation against the accused is that they had supplied 7 tablets instead of 8 tablets and they had collected excess amount of Rs.1.12 from the complainant. It is not the case of the prosecution that the accused persons had collected excess amount than the price indicated on the label of the container or pack thereof, whichever is less.”
The ruling thus turned on the relationship between the allegations and the statutory offence invoked. The court did not treat the allegation of short supply as sufficient, by itself, to establish a prosecution under Clause 26.
Holding that continuation of the case was unwarranted, the court stated:
“Under the circumstances, I am of the opinion that prosecution of the petitioners for the aforesaid offences would not only cause embarassment to them, but would also amount to abuse of process of law.”
The exact operative ruling in paragraph 7 reads:
“Petitions are allowed. The entire proceedings in C.C.No.7712/2019 pending before the Court of III Addl. Metropolitan Magistrate, Bengaluru, for the offences punishable under Clause 26 of the Drugs (Price Control) Order, 2013, and Section 7(1)(a)(ii) of the Essential Commodities Act, 1955, stands quashed.”
The decision terminates the specified criminal proceedings against all five petitioners. Its reasoning concerns the failure of the allegations to attract the price-control offence invoked; the order does not separately determine whether the alleged tablet shortage occurred.
To view the official order, click the link below:
Mpharm (Pharmacology)
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

